A study of the teratogenic and fetotoxic effects of large doses of amobarbital used for a suicide attempt by 14 pregnant women

Abstract

The teratogenic effect of barbitals is debated, and this study was performed to identify the effects of very large doses of amobarbital used for suicide attempts during pregnancy on embryo–fetal development. Self-poisoned pregnant women were identified from patients of the Department of Toxicology Internal Medicine, Korányi Hospital, Budapest, Hungary, who were admitted from the 3 million people of Budapest and its surrounding region. A comparison was made between outcomes of pregnancies of women who attempted suicide with amobarbital alone or in combination with other drugs during pregnancy with sib controls. Of 1044 women with self-poisoning during pregnancy between 1960 and 1993, 33 used amobarbital for a suicide attempt. Of these 33 women, 14 delivered live-born babies. The dose of amobarbital taken by these women ranged between 600 and 10,000 mg, with a mean of 3886 mg. Of the 14 amobarbital-exposed children, 9 had mothers who attempted suicide between the 3rd and 12th post-conceptional weeks. None of these children had a congenital abnormality, and there was no evidence of fetal growth retardation. The distribution of cognitive status and behavioral scale of the exposed children were comparable with those of their sibs although one exposed child had a very low (about 75) IQ, whereas another one was treated because of a very severe aggressive behavioral deviation. Exposure to very large doses of amobarbital that were used for self-poisoning during pregnancy did not produce teratogenic effects in this study.

Keywords

amobarbital congenital abnormalities birth weight pregnancy age cognitive and behavioral development suicide attempt during pregnancy

Get full access to this article

View all access options for this article.

References

Briggs GG Freeman RK Yaffe SJ (2005) Drugs in Pregnancy and Lactation, seventh ed. Philadelphia: Lippincott Williams and Wilkins.

Czeizel AE (1986) Self-poisoning as a model for the study of mutagenicity and teratogenicity of chemicals on human beings. In: C Ramel B Lambert J Magnusson (eds), Genetic Toxicology of Environmental Chemicals. Part B: Genetic Effects and Applied Mutagenesis. New York: Alan R. Liss, pp. 237–244.

Czeizel AE (1994) Budapest registry of self-poisoned patients. Mutat Res 312: 157–163.

Czeizel AE Bod M Halász P (1992) Evaluation of anticonvulsant drugs during pregnancy in a population-based Hungarian study. Eur J Epidemiol 8: 122–127.

Czeizel AE Gidai J Petik D Timmermann G Puho EH (2008) Self-poisoning during pregnancy as a model for teratogenic risk estimation of drugs. Toxicol Ind Health 24: 11–28.

Czeizel AE Lendvay A (1989) Attempted suicide and pregnancy. Am J Obstet Gynecol 161: 497(only).

Czeizel AE Petik D Puhó E (2004) Smoking and alcohol drinking during pregnancy: the validity of retrospective maternal self-reported information. Cent Eur J Public Health 12: 179–183.

Czeizel AE Rockenbauer M Siffel CS Varga E (2001) Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology 63: 176–185.

Czeizel AE Szentesi I Szekeres I Glauber A Bucski P Molnár C (1984) Pregnancy outcome and health conditions of offspring of self-poisoned pregnant women. Acta Paediatr Hung 25: 209–236.

10.

Czeizel AE Szentesi I Szekeres I Molnár G Glauber A Bucski P (1988) A study of adverse effects on the progeny after intoxication during pregnancy. Arch Toxicol 62: 1–7.

11.

Czeizel AE Tomcsik J Tímár L (1997) Teratologic evaluation of 178 infants born to mothers who attempted suicide by drugs during pregnancy. Obstet Gynecol 90: 195–201.

12.

Draffan GH Dollery CT Davies DS Krauer B Williams FM Clare RA Trudinger BJ Darling M Sertel H Hawkins DF (1976) Maternal and neonatal elimination of amobarbital after treatment of the mother with barbiturates during late pregnancy. Clin Pharmacol Ther 19: 271–275.

13.

Favre-Tissot M (1967) An original clinical study of the pharmacologic–teratogenic relationship. Ann Med Psychol (Paris) 3: 389–394.

14.

Food and Drug Administration (FDA) (1980) Fetal risk summary. Fed Regist 44: 37434–37467.

15.

Heinonen PO Slone D Shapiro S (1977) Birth Defects and Drugs in Pregnancy. Littleton, Mass: John Wright Publishing Sciences Group.

16.

Jago RH (1970) Arthrogryposis following treatment of maternal tetanus with muscle relaxants. Arch Dis Child 45: 277–279.

17.

Janz D Fuchs V (1964) Are anti-epileptic drugs harmful when given during pregnancy. Ger Med Mon 9: 20–23.

18.

Kraver B Draffan GH Williams FM Clare RA Dollery CT Hawkins DF (1973) Elimination kinetics of amobarbital in mothers and newborn infants. Clin Pharmacol Ther 14: 442–447.

19.

Lendvay A Czeizel AE (1992) A behavioural teratologic study on offspring of self-poisoned pregnant women. Acta Paediatr Hung 32: 347–369.

20.

Nelson MM Forfar JO (1971) Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. BMJ 1: 523–527.

21.

Shepard TH Lemire RJ (2004) Catalog of Teratogenic Agents, eleventh ed. Baltimore: Johns Hopkins University Press.

22.

Szegal B (1980) Diagnostic of psychomotor development. Hung Psychol 37: 148–188.